Nanovaccine Designed for Splenic Delivery Augments Immune Responses for Tumor Therapy
Xinlong Zang(Qingdao University), Zhaohe Niu(Qingdao University), Zhenghui Jing(Qingdao University), Ping Shuai(University of Electronic Science and Technology of China), Zimin Liu(Qingdao University), Ke Lei(Qingdao University), Youcai An(Shaanxi University of Chinese Medicine), Jia Wang(Nanchong Central Hospital)
Cited by 0
Related Papers
Global, regional, and national burden of chronic kidney disease and its underlying etiologies from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
|BMC Public Health|2025|148
Detection of serum IgM and IgG for COVID-19 diagnosis
|Science China Life Sciences|2020|107
Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis
|BMC Medicine|2023|89
Identification and validation of a ferroptosis‐related gene signature for predicting survival in skin cutaneous melanoma
|Cancer Medicine|2022|66
NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation
|The FASEB Journal|2017|62